X
Xianzhi Liu
Researcher at Zhengzhou University
Publications - 12
Citations - 409
Xianzhi Liu is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 1, co-authored 1 publications receiving 250 citations.
Papers
More filters
Journal ArticleDOI
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang,Do-Hyun Nam,Zvi Ram,Wai Sang Poon,Jiguang Wang,Damdindorj Boldbaatar,Ying Mao,Wenbin Ma,Qing Mao,Yongping You,Chuanlu Jiang,Xuejun Yang,Chunsheng Kang,Xiaoguang Qiu,Wenbin Li,Shaowu Li,Ling Chen,Xuejun Li,Zhixiong Liu,Weimin Wang,Hongmin Bai,Yu Yao,Shouwei Li,Anhua Wu,Ke Sai,Guilin Li,Kun Yao,Xinting Wei,Xianzhi Liu,Zhiwen Zhang,Yiwu Dai,Sheng-Qing Lv,Liang Wang,Zhixiong Lin,Jun Dong,Guozheng Xu,Xiaodong Ma,Wei Zhang,Chuanbao Zhang,Baoshi Chen,Gan You,Yongzhi Wang,Yinyan Wang,Zhaoshi Bao,Pei Yang,Xing Fan,Xing Liu,Zheng Zhao,Zheng Wang,Yiming Li,Zhiliang Wang,Guanzhang Li,Shengyu Fang,Lianwang Li,Yanwei Liu,Shuai Liu,Xia Shan,Yu-Qing Liu,Ruichao Chai,Huimin Hu,Jing Chen,Wei Yan,Jinquan Cai,Hongjun Wang,Lingchao Chen,Yuan Yang,Yu Wang,Lei Han,Qixue Wang +68 more
TL;DR: The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost and should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutionsinvolved in the cost regulation of cancer care in China.
Journal ArticleDOI
Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma
TL;DR: Zhang et al. as mentioned in this paper explored the mechanism of glioma from the MYB family genes from the perspective of the circRNA-miRNA-mRNA regulatory network.
Journal ArticleDOI
The Efficacy and Safety of Deep Brain Stimulation of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens (ALIC/NAcc-DBS) for Treatment-Refractory Obsessive-Compulsive Disorder: Protocol of a Multicenter, Randomized, and Double-Blinded Study
Tingting Xu,Yuan Gao,Bin Li,Jiaxin Jiang,Huirong Guo,Xianzhi Liu,Hongxing Huang,Yuqi Cheng,Hualin Yu,Jie Hu,Xi Wu,Wei Wang,Zhen Wang +12 more
TL;DR: This protocol aims to explore the efficacy and safety of the combined ALIC- and NAcc-DBS for treatment-refractory OCD, determined by treatment response rate between the active and sham-stimulation groups at the double-blind stage and spontaneously reported adverse events.
Journal ArticleDOI
National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019–2020
Dan Xiao,Chang-Shuai Yan,De-zhi Li,Tianshu Xi,Xianzhi Liu,Dan Zhu,Guodong Huang,Jianguo Xu,Zhengwen He,Anhua Wu,Chiyuan Ma,Jiang Long,Kai Shu,Hongming Ji,Ning Wang,Gang Chen,Jian Yang,Huizhuo Ma,Zhiyong Li,Xiaochuan Sun,Y. Qu,Zhixiong Liu,Chunlei Tian,Shilei Ni,Renya Zhan,Liwen Chen,Ming Ge,Maode Wang,Xiao-Bo Jiang,Geng Guo,Zhen Han,chuanzi Zhang,Ting Zhang,Chang-wu Dou,Liangzhao Chu,Pengcheng Wang,Ju-Mei Shao,Xiyue Wu,Juncheng Yu,Yu Wang,Nan Wu,Rui Zhang,Mingming Zhang,Yong Hong,Jian-zhong Gao,Yunqian Li,Yawen Pan,Bing Zhao,Nan Ji,Guangliang Shan,Chirag J. Patel,Wang-qian Jia,Liwei Zhang +52 more
TL;DR: The National Brain Tumour Registry of China (NBTRC) is the first multi-hospital-based brain tumour registry in China as discussed by the authors , which was created in 2019 and used to compare epidemiologic data across the globe.
Journal ArticleDOI
Diffusion tensor imaging-based machine learning for IDH wild-type glioblastoma stratification to reveal the biological underpinning of radiomic features.
Zilong Wang,F. Guan,Wenchao Duan,Yu Guo,Dongling Pei,Yuning Qiu,Minkai Wang,Aoqi Xing,Zhongyi Liu,Bin Yu,Hongwei Zheng,Xianzhi Liu,Dongming Yan,Yuchen Ji,Jingliang Cheng,Jing Yan,Zhenyu Zhang +16 more
TL;DR: In this article , a DTI-based radiomic signature was used for predicting prognosis in patients with IDH wild-type GBM and reveal the biological underpinning of individual DTI radiomic features and metrics.